Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging

International Journal of Cancer

Volumn 79, Issue 5, 1998, Pages 521-525

  Nishiya, Masashi ^a   Sakuragi, Noriaki ^a   Hareyama, Hitoshi ^a   Ebina, Yasuhiko ^a   Furuya, Mitsuko ^a   Oikawa, Mamoru ^a   Yamamoto, Ritsu ^a   Fujino, Takafumi ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 0031691793     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981023)79:5<521::AID-IJC13>3.0.CO;2-4     Document Type: Article

References (18)

1. AMBROS, R.A. and KURMAN, R.J., Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer, 69, 1424-1431 (1992).
2. CHAMBERS, F.T., MCCLUSKY, N., EISENFIELD, A., KOHORN, E.I., LAWRENCE, R. and SCHWARTZ, P.E., Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer. Gynecol. Oncol., 31, 65-77 (1988).
3. EBINA, Y., HAREYAMA, H., SAKURAGI, N., YAMAMOTO, R., FURUYA, M., SOGAME, M., FUJINO, T., MAKINODA, S. and FUJIMOTO, S., Peritoneal cytology and its prognostic value in endometrial carcinoma. Int. Surg., 82, 244-248 (1997).
4. FIGO (INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS). FIGO news, Corpus cancer staging. Int. J. Gynecol. Obstet., 28, 190 (1989).
5. GRIMSHAW, R.N., TUPFER, W.C., FRASER, R.C., TOMPKINS, M.G. and JEFFREY, J.F., Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol. Oncol., 36, 97-100 (1990).
6. HANSOM, M.B., VAN NAGELL, J.R., JR., POWELL, D.E., DONALDSON, E.S., GALLION, H., MERHIGE, M. and PAVLIK, E.J., The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer, 55, 1753-1757 (1985).
7. HIRAHATAKE, K., HAREYAMA, H., SAKURAGI, N., NISHIYA, M., MAKINODA, S. and FUJIMOTO, S., A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J. surg. Oncol., 65, 82-87 (1997).
8. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. The general rules for the gastric cancer study (11th ed.), pp. 64-66, Kanehara Shuppan, Tokyo (1985).
9. KADAR, N., HOMESLEY, H.D. and MALFETANO, J.H., Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extra-uterine disease. Gynecol. Oncol., 46, 145-149 (1992a).
10. KADAR, N., MALFETANO, J. and HOMESLEY, H., Determinants of survival of surgically staged patients with endometrial carcinoma histologically con- fined to the uterus; implications for therapy. Obstet. Gynecol., 80, 1655-1659 (1992b).
11. KURMAN, R.J. and NORRIS, H.J., Endometrial carcinoma. In: R.J. Kurman and H.J. Norris (eds.), Blaustein's pathology of The female genital tract (3rd ed.), pp. 338-372, Springer, New York (1987).
12. MITTAL, K.R., SCHWARZ, P.E. and BARWICK, K.W., Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer, 61, 538-545 (1988).
13. SAKURAGI, N., TANAKA, T., SATOH, C., NISHIYA, M., OHKOUCHI, T., TSUMURA, N., TAKEDA, N., HIRAHATAKE, K., SAGAWA, T., OHKUBO, H. and FUJIMOTO, S., Extracorporeal spread and its prognostic impact in stages I and II (FIGO) endometrial carcinoma. Asia-Oceania J. Obstet. Gynaecol., 17, 193-201 (1991).
14. SOONG, R., KNOWLES, S., WILLIAMS, K.E., HAMMOND, I.G., WYSOCKI, S.J. and IACOPETTA, B.J., Over-expression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Brit. J. Cancer, 74, 562-567 (1996).
15. VAN DER PUTTEN, H.W.H.M., BAAK, J.P.A., KOENDERS, T.J.M., KURVER, P.H.J., STOLK, H.G. and STOLTE, L.A.M., Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma. Cancer, 63, 1378-1387 (1989).
16. VECEK, N., MARINOVIC, T., IVIC, J., JUKIC, S., NOLA, M., DZANICCEMALOVIC, N. and VECEK, N., JR., Prognostic impact of peritoneal cytology in patients with endometrial carcinoma. Europ. J. Gynaecol. Oncol., 14, 380-385 (1993).
17. WILSON, T.D., PODRATZ, K.C., GAGGEY, T.A., MALKASIAN, G.D., JR., O'BRIEN, P.C. and NAESSENS, J.M., Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Amer. J. Obstet. Gynecol., 162, 418-423 (1990).
18. ZAINO, R.J., KURMAN, R.J., DIANNA, K.L. and MORROW, C.P., Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer, 77, 1115-1121 (1996).